AB

Alta Bioequities

Description

Alta Bioequities

Investor Profile

Alta Bioequities has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Life Science.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Life Science
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alta Bioequities frequently co-invest with?

SC
North America, New York, United States, New York
Co-Investments: 1
Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 1
AV
North America, New York, United States, New York
Co-Investments: 1
AC
North America, California, United States, Belmont
Co-Investments: 1
RTW Investments
North America, New York, United States, New York
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 1
Avoro Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Alta Bioequities?

Aadi Bioscience

Pacific Palisades, California, United States

Aadi Bioscience develops a potentially mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.

BiopharmaBiotechnologyLife ScienceOncology
Post Ipo EquityAug 26, 2021
Amount Raised: $154,999,876